|
Sept. 12, 2005 |
|
|
Dec. 17, 2018 |
|
|
jRCT2080220084 |
Multicenter, double-blind randomized, controlled study for the treatment of involutional osteoporosis |
|
| version: date: |
Ono Pharmaceutical Co., Ltd. |
||
06-6263-5670 |
||
Interventional |
||
double-blind randomized, controlled study |
||
3 |
||
Patients of female aged 55 years or older and under 81 years with documented involutional osteoporosis with prevalent fracture according to the diagnostic criteria for primaly osteoporosis |
||
| 55age old over | ||
| 80age old under | ||
Female |
||
Involutional osteoporosis |
||
investigational material(s) |
||
Efficacy, Safety |
||
| ONO PHARMACEUTICAL CO.,LTD. | |
| JapicCTI-050086 | |